Small Intestine

Advertisement

cGxPJobs Banner

Syntis Bio Advances Oral SYNT-101 Toward Phase 2

BOSTON — September 15, 2026 Syntis Bio, Inc. announced results from the 28-day multiple-ascending-dose (MAD) portion of its Phase...

By cGxPwire Editor
September 16, 2026

Read More

Advertisement

cGxPJobs

Directory